While the historical EPS growth rate for Phibro is 0.9%, investors should actually focus on the projected growth. The company's EPS is expected to grow 35.7% this year, crushing the industry average, ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

In today’s Daily Kickoff, we look at possible pathways forward for the Antisemitism Awareness Act in the new Congress and report on President–elect Donald Trump’s appointment of Morgan Ortagus as ...

StockNews.com upgraded shares of Phibro Animal Health (NASDAQ:PAHC – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Saturday morning. Other analysts ...

PAHC shares gain owing to the remarkable performance of the Animal Health business and potential in the emerging markets.

Navigating the complexities of dairy farming requires meticulous attention to detail, especially when dealing with the ...